BofA Discloses 172,091‑Share Position in RxSight, Classified as Passive

Rhea-AI Filing Summary

Bank of America Corporation reports beneficial ownership of 172,091 shares of RxSight, Inc. common stock, representing 0.4% of the class. The filing shows 0 shares with sole voting or dispositive power, 151,216 shares with shared voting power and 172,091 with shared dispositive power, reflecting holdings across Bank of America and several wholly owned subsidiaries. The statement affirms the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. Ownership is below the 5% threshold that typically signals a controlling stake.

Positive

• Transparent disclosure of beneficial ownership: 172,091 shares representing 0.4% of RxSight common stock
• Certification of ordinary‑course holdings, stating the position was not acquired to influence control

Negative

• None.

Insights

Financial Analyst

TL;DR: Non‑material institutional stake; routine disclosure with shared custody characteristics.

Bank of America’s reported 172,091‑share position (0.4%) is immaterial to RxSight’s capital structure and unlikely to affect operations or strategic direction. The split between shared voting power (151,216) and shared dispositive power (172,091) suggests holdings managed across multiple BofA entities, consistent with brokerage, custody or client‑related positions rather than an active control intent. The certification that the position is held in the ordinary course reinforces a passive posture.

Corporate Governance Expert

TL;DR: Schedule 13G/A indicates passive ownership across bank and broker subsidiaries, not a control claim.

The filing names Bank of America Corporation and identifies specific subsidiaries (broker‑dealers, a bank and a non‑U.S. institution) as holders. The explicit statement that the securities were not acquired to change or influence control and the classification under Schedule 13G/A are consistent with passive investor status. From a governance perspective, this disclosure is routine and does not signal governance change or activist intent.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

RxSight, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

78349D107

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 78349D107

1

Names of Reporting Persons

BANK OF AMERICA CORP /DE/

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 151,216.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 172,091.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

172,091.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.4 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: RxSight, Inc.
(b)	Address of issuer's principal executive offices: 100 COLUMBIA STREET, 100 COLUMBIA STREET, ALISO VIEJO, CALIFORNIA, 92656.
Item 2.
(a)	Name of person filing: BANK OF AMERICA CORP /DE/
(b)	Address or principal business office or, if none, residence: 100 N TRYON ST CHARLOTTE, NC 28255
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 78349D107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 172,091.00
(b)	Percent of class: 0.4%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0.00
	(ii) Shared power to vote or to direct the vote: 151,216.00
	(iii) Sole power to dispose or to direct the disposition of: 0.00
	(iv) Shared power to dispose or to direct the disposition of: 172,091.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. This statement on Schedule 13G is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); Bank of America N.A., a bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); Merrill Lynch Pierce Fenner & Smith, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); and Merrill Lynch International, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J).
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BANK OF AMERICA CORP /DE/

Signature:	Andres Ortiz
Name/Title:	Authorized Signatory
Date:	08/12/2025

FAQ

How many RxSight (RXST) shares does Bank of America report owning?

Bank of America reports owning 172,091 shares of RxSight common stock, representing 0.4% of the class.

Does Bank of America have voting control over RxSight (RXST)?

No. The filing shows 0 shares with sole voting power and states the securities are held in the ordinary course of business and not to influence control.

Which Bank of America entities are identified as holders of the RXST position?

The statement is filed on behalf of Bank of America Corporation and wholly owned subsidiaries, including BofA Securities, Inc., Bank of America N.A., Merrill Lynch Pierce Fenner & Smith, Inc., and Merrill Lynch International.

Is this a 5% ownership filing for RxSight (RXST)?

No. The reported ownership is 0.4%, which is below the 5% level that typically indicates a larger, potentially controlling stake.

What type of SEC filing is this and what does it signify?

This is a Schedule 13G/A amendment disclosing beneficial ownership under rules for passive or ordinary‑course holdings rather than active control filings.